Trial intelligence / Profile preview

Amyvid Reader Accuracy with Quantitation

NCT02107599Phase 4Completed

Sponsor
Avid Radiopharmaceuticals
Start
Mar 2014
Primary completion
May 2014
Countries
1
01

Overview

Phase 4, open-label, single-arm trial, sponsored by Avid Radiopharmaceuticals. Primary endpoint: Change in Reader Accuracy After Application of Quantitation Software. Started Mar 2014; status: completed.

Beyond the preview

Go deeper on NCT02107599.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02107599.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call